- June 27, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Androcur, Androcur depot, MED- Cyproterone, Riva-Cyproterone
Synonyms :
Class :
Antineoplastic agents & Antiandrogens
Dosage Forms & Strengths
Oil, Intramuscular:
100mg/ml (3ml)
Tablet, Oral:
50 mg
hormone adjunct therapy for transgender females
25 - 50
mg
Orally
once a day
in combination with other appropriate agents; adjust the dose to suppress serum testosterone levels into the normal range for females.
50 - 200
mg
Orally
once a day
(do not exceed 600 mg/day)
or
300 to 600 mg IM every 1 to 2 weeks or
400 to 700 mg IM once a week
Do not use if hepatic failure, thromboembolic disease, or active pituitary pathology.
200 - 300
mg
Orally
given in 2 to 3 divided doses in a day.
Or
300 mg IM once a week, reduce the dose to 300 mg once every 2 weeks depending on clinical symptoms.
Dose Adjustments
Meningioma: Terminate the cyproterone administration permanently.
Thrombophlebitis/thromboembolism: Discontinue treatment.
Prostate-specific antigen progression: discontinue cyproterone treatment and monitor for withdrawal symptoms.
No safe dosing is established
Refer to adult dosing
CYP3A Inhibitors: they may diminish the serum concentration of hormonal agents
CYP3A Inhibitors: they may diminish the serum concentration of hormonal agents
CYP3A Inhibitors: they may diminish the serum concentration of hormonal agents
CYP3A Inhibitors: they may diminish the serum concentration of hormonal agents
CYP3A Inhibitors: they may diminish the serum concentration of hormonal agents
antiandrogens decrease the efficacy of choline C11
indium In-111 capromab pendetide
may decrease the diagnostic effect when combined
indium In-111 capromab pendetide
may decrease the diagnostic effect when combined
antiandrogen may decrease the therapeutic efficacy of Choline C 111
may reduce the effective serum concentration of cyproterone
may reduce the therapeutic efficacy of progestins and vice versa
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
it may increase the levels of serum concentration
may increase the hypertensive effect of hypertension-associated agents
may enhance the serum concentration of HMG-CoA Reductase Inhibitors
they decrease the efficacy of choline C11
Frequency not defined:
Acute myocardial infraction
Edema
Hypotension
Phlebitis
Cardiac failure
Pulmonary embolism
Retinal thrombosis
Tachycardia
Vasodepressor syncope
Excessive sweating
Eczema
Erythema nodosum
Exfoliative dermatitis
Loss of body hair
Pruritis
Skin discoloration
Skin rash
Urticaria
Xeroderma
Ascites
Hepatic necrosis
Hypersensitivity reaction
Asthenia
Optic atrophy
Optic neuritis
Visual disturbance
Asthma
Cough
Dyspnea
Hyperventilation
Pulmonary fibrosis
Fever
Pregnancy consideration: Avoid use in patients who can become pregnant.
Lactation: Cyproterone can be excreted in breast milk, avoid use in lactating females.
Pregnancy category:
Patient information leaflet
Generic Name: Cyproterone
Pronounced: si-pro-te-ron
Why do we use cyproterone?
Cyproterone is an antiandrogen class of antineoplastic drug. It is used to treat prostate cancer.